Diagnolita
@diagnolita.lt
A start-up company developing innovative molecular diagnostics assays. We aim to translate achievements of genomics and our deep knowledge as well as experience in life science technologies such as qPCR, NGS, etc. to molecular diagnostics for medicine.
Diagnolita's Company Logos
Diagnolita's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#00AEEF
Cerulean
0, 174, 239
196, 100, 47
100, 27, 0, 6
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#0F75BC
Denim
15, 117, 188
205, 85, 40
92, 38, 0, 26
About Diagnolita
Diagnolita is a leading molecular diagnostics brand founded in 2013, specializing in innovative non-invasive diagnostics for oncology and infectious diseases. Their state-of-the-art licensed laboratory adheres to international standards, ensuring reliable test results. With a team of highly qualified specialists, Diagnolita has 9 years of experience in scientific and biomedical research, developing cutting-edge diagnostic methods.
Their services include non-invasive early prostate cancer diagnostics, genetic testing for hereditary breast and ovarian cancer, and COVID-19 PCR testing from saliva samples. The COVID-19 test is sensitive and specific, identifying all known variants of the SARS-CoV-2 virus. Additionally, they offer genetic testing for hereditary breast and ovarian cancer using advanced technology, allowing for sample collection at home.
Diagnolita aims to empower individuals to improve their health by leveraging the latest scientific advancements in molecular diagnostics.
Company type
Privately Held
Year founded
2013
Company size
2-10 employees
